Overview

CAR T Cells in Mesothelin-Expressing Breast Cancer

Status:
Not yet recruiting
Trial end date:
2038-01-01
Target enrollment:
Participant gender:
Summary
Phase 1 - Safety and Proof of Concept
Phase:
Phase 1
Details
Lead Sponsor:
University of Pennsylvania